CANDEL THERAPEUTICS INC

Insider Trades Show Confidence, Not Volatility: Candel Therapeutics’ Strategic Position

Insider trades at Candel Therapeutics show routine selling and option buying, underscoring leadership confidence as the AURORA oncolytic virus trial drives future upside.

CANDEL THERAPEUTICS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

01/07/2026, 22:40

4 minutes to read

Insider Buy‑Options Surge at Candel Therapeutics: 8 Executives Secure 32K Each, Signaling Strong Future Growth

Insider buys 32,000 zero‑price options at Candel Therapeutics, signaling strong confidence ahead of clinical milestones and potential price gains.

CANDEL THERAPEUTICS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

24/06/2026, 22:52

3 minutes to read